Learn about assessment, intervention, and teaching for patients with this progressive debilitating disease.
Reader Survey
Please share your feedback! We’re interested to learn more about your experience with American Nurse Journal.
Parkinson’s disease
FDA approves first drug for hallucinations and delusions associated with PD
On April 29, the U.S. the Food and Drug Administration (FDA) approved Nuplazid (pimavanserin) tablets, the first drug approved to…
FDA approves new drug for Parkinson’s disease
On March 21, the U.S. Food and Drug Administration (FDA) approved Xadago (safinamide) tablets as an add-on treatment for patients…
Managing medications for hospital patients with Parkinson disease
A progressive degenerative disease, Parkinson disease (PD) is marked by tremor, slow movement, stiffness, and balance problems. It affects about 1…
New MRI technique may help in early diagnosis of Parkinson’s disease
Researchers have developed a simple MRI technique that may help in the early diagnosis of Parkinson’s disease. Read more and…
Parkinson disease and melanoma
People with Parkinson’s disease have a higher risk of melanoma and vice versa, according to a study in the Mayo…
Statins and Parkinson’s disease
Use of statins is associated with a higher risk for Parkinson’s disease, according to a study in Movement Disorders. Objective…
Get your free access to the exclusive newsletter of American Nurse Journal and gain insights for your nursing practice.
NurseLine Newsletter
*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.